metastatic cancer

2019 ASCO ® Annual Meeting; #ASCO19
June 3, 2019
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2019: Laparoscopic Surgery for Metastatic Colorectal Cancer, Expanding Eligibility Criteria for Advanced Non-Small Cell Lung Cancer, and a New Targeted Therapy for Advanced Bladder Cancer

English
gregguthrie

The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include minimally invasive surgery for liver metastases in colorectal cancer, expanding clinical trial eligibility criteria for non-small cell lung cancer, and a new targeted therapy for advanced bladder cancer.

Read More >>
December 20, 2018
Richard L. Schilsky, MD, FACP, FSCT, FASCO

Tumor-Agnostic Treatment for Cancer: An Expert Perspective

English
Richard.Schilsky

Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.

Read More >>
June 27, 2018
Stephanie L. Graff, MD, and Kelly Shanahan, MD

Being a Physician-Patient Is a Double-Edged Sword

English
Stephanie.Graff.Kelly.Shanahan

"I know too much. I don't know enough." Dr. Stephanie L. Graff interviews Dr. Kelly Shanahan, an OB/GYN living with metastatic breast cancer, about what it is like being a patient who is also a doctor.

Read More >>

Pages

Subscribe to RSS - metastatic cancer